Myovant Sciences and HealthyWomen Launch Storytelling Initiative to Elevate Conversations About Menstrual Health - Seite 2
The initiative aims to shed light on the impact of menstrual stigma and symptoms by sharing women’s lived experiences. Myovant and HealthyWomen have partnered with The Moth to host a storytelling workshop for participating women. Those interested in sharing their stories are encouraged to visit FemaleForwardTogether.com for more information about how to apply.
About Myovant Sciences
Myovant Sciences aspires to be the leading healthcare company focused on innovative treatments for women’s health and prostate cancer. The company’s lead product candidate is relugolix, a
once-daily, oral GnRH receptor antagonist. The company has three late-stage clinical programs for relugolix in uterine fibroids, endometriosis, and prostate cancer. The company is also
developing MVT-602, an oligopeptide kisspeptin-1 receptor agonist, that has completed a Phase 2a study for the treatment of female infertility as part of assisted reproduction. Takeda
Pharmaceuticals International AG, a subsidiary of Takeda Pharmaceutical Company Limited, the originator of relugolix, previously granted the company a worldwide license to develop and
commercialize relugolix (excluding Japan and certain other Asian countries) and an exclusive license to develop and commercialize MVT-602 in all countries worldwide. Sumitovant Biopharma, Ltd., a
wholly owned subsidiary of Sumitomo Dainippon Pharma Co., Ltd., is the majority shareholder of Myovant. For more information, please visit the company’s website at www.myovant.com. Follow @Myovant on Twitter and LinkedIn.
Lesen Sie auch
About HealthyWomen
HealthyWomen is the nation's leading independent, nonprofit health information source for women. Our mission is to educate, engage and inspire women, ages 35 to 64, to make informed health choices
to live and age well. We engage with health care professionals, patient advocates, policy makers, NGOs and corporate partners to better inform our educational resources so that we can provide our
audience with the most reliable, medically-accurate, balanced health information. For 30+ years, millions of women have turned to HealthyWomen for answers to their most personal health care
questions.